Today's health news includes UnitedHealth's big bet in AI, RFK Jr. endorsing peptides but not vaccines, and more
As part of the deal, Neurocrine will pick up an approved drug for the rare disease Prader-Willi syndrome, which has seen a successful launch.
Medicare Advantage rates, a health system monopoly forms, hospitals and insurer face off in Texas, and more from STAT's Health Care Inc.
By the time FDA agreed to meet with Kezar Life Sciences it was in the process of closing. The chain of events fits a pattern of FDA volatility recently.
When a child presents to the emergency department again and again in psychiatric crisis, the response should evolve.
Medical foods are regulated differently than drugs, allowing insurers to classify them as optional. That must change.
RFK Jr.'s apparent contradiction on vaccines and peptides reflects a deeper belief: Americans have a right to try and can choose their own risks.
